Avanos Medical(NYSE) AVNS

Avanos makes devices that help patients eat and manage pain. Its products provide nutrition to people who cannot eat normally. These tools also help patients recover without using addictive painkillers.

What Does Avanos Make?

• MIC-KEY feeding tubes: Devices for digestive health used to deliver nutrition; accounted for more than 10% of net sales in 2025.
• Corpak solutions: Patient feeding tools used for specialized nutrition; accounted for more than 10% of net sales in 2025.
• NeoMed products: Feeding systems designed for infants and children; accounted for more than 10% of net sales in 2025.
• Non-opioid pain relief: Surgical pumps and thermal therapies like COOLIEF that treat pain without using addictive narcotic drugs.
• Vascular access: Medical tools used to reach the bloodstream through veins or arteries; expanded through recent acquisitions.

Reshaping the Company Portfolio

• Acquired Nexus Medical, LLC in September 2025 to enter the vascular access market for $27 million.
• Sold the Respiratory Health business in October 2023 for $110 million to focus on core segments.
• Acquired Diros Technology Inc. in July 2023 for approximately $53 million to add new chronic pain treatments.
• Sold the HA product line and Game Ready rental business in 2025 to align with restructuring goals.

A Global Reach in Healthcare

The company generates approximately 22% of its net sales outside of North America and operates manufacturing plants in the United States, Mexico, and Canada. Its distribution relies heavily on third-party partners, with sales to Medline Industries accounting for 12% of total net sales in 2025.

Recent Financial Performance

• Net sales reached $180.9 million in Q4 2025, up 0.7% from the same period in 2024.
• Net income turned positive at $3.7 million in Q4 2025, improved from a loss of $397.3 million in Q4 2024.
• Operating income fell to -$89.3 million in Q4 2025, worsened from $12.5 million in Q4 2024.
• Free cash flow was $21.3 million in Q4 2025, down 59.9% from the previous year.

Bottom Line

Avanos has narrowed its focus by selling its respiratory business and acquiring specialized technology in pain and nutrition. This shift moves the company toward medical device markets where it holds established brand positions.